What biotech consulting services does RMS offer?

RMS offers personalized biotech consulting services drawing on its deep scientific expertise in regenerative medicine, iPSC biology, and translational research. These services are designed for biotechnology companies, pharmaceutical organizations, and research institutions that want access to specialist knowledge in stem cell development and therapy translation, either to support their own internal programs or to evaluate new scientific opportunities.

RMS’s consulting offering is shaped by its own experience as a biotech company that is translating over two decades of academic stem cell research into a commercial therapeutic program. That hands-on perspective, navigating the scientific, regulatory, and strategic challenges of bringing an iPSC-based therapy from the laboratory toward the clinic, is what distinguishes RMS from conventional biotech consulting firms whose insights are primarily analytical rather than experiential.

Consulting engagements can be scoped to cover a range of objectives, including scientific feasibility assessment for new stem cell programs, strategy development for iPSC platform buildout, differentiation protocol optimization, preclinical program design, regulatory pathway planning, and partnership and licensing strategy. RMS works with clients across the United States and internationally, offering flexible engagement models including virtual consulting for global clients.

Learn more about RMS’s biotech consulting services.